A. Ido

438 total citations
18 papers, 357 citations indexed

About

A. Ido is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, A. Ido has authored 18 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in A. Ido's work include Liver Disease Diagnosis and Treatment (4 papers), Virus-based gene therapy research (3 papers) and Hepatitis B Virus Studies (3 papers). A. Ido is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Virus-based gene therapy research (3 papers) and Hepatitis B Virus Studies (3 papers). A. Ido collaborates with scholars based in Japan, United States and Canada. A. Ido's co-authors include Fukiko Komaki, Yuga Komaki, Atsushi Sakuraba, Dejan Micić, Akihiro Yamada, Satoru Hasuike, Hirofumi Uto, Katsuhiro Hayashi, Kazunori Kusumoto and Hidekazu Nakabayashi and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Oncology and Journal of Dental Research.

In The Last Decade

A. Ido

18 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Ido Japan 11 128 108 94 89 81 18 357
Lorna Charles United States 8 228 1.8× 391 3.6× 123 1.3× 134 1.5× 44 0.5× 34 557
Rick TH Ong Singapore 4 82 0.6× 110 1.0× 83 0.9× 83 0.9× 48 0.6× 5 403
Victoria M. Velazquez United States 11 215 1.7× 101 0.9× 144 1.5× 139 1.6× 164 2.0× 16 505
Isabel González-Gascón-y-Marín Spain 12 86 0.7× 45 0.4× 33 0.4× 84 0.9× 30 0.4× 32 335
Jonathan Parker United States 7 130 1.0× 66 0.6× 87 0.9× 60 0.7× 13 0.2× 12 329
Angus W. Thomson United States 10 62 0.5× 85 0.8× 90 1.0× 375 4.2× 63 0.8× 15 639
Ann Truelove United States 8 94 0.7× 41 0.4× 50 0.5× 57 0.6× 72 0.9× 9 289
Juan Zhao China 12 75 0.6× 70 0.6× 227 2.4× 57 0.6× 29 0.4× 34 477
Xiaoying Lei China 11 84 0.7× 16 0.1× 123 1.3× 56 0.6× 47 0.6× 22 348
Alice Miles United Kingdom 8 159 1.2× 119 1.1× 114 1.2× 217 2.4× 226 2.8× 8 598

Countries citing papers authored by A. Ido

Since Specialization
Citations

This map shows the geographic impact of A. Ido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ido more than expected).

Fields of papers citing papers by A. Ido

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ido. The network helps show where A. Ido may publish in the future.

Co-authorship network of co-authors of A. Ido

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ido. A scholar is included among the top collaborators of A. Ido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ido. A. Ido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kusakisako, Kodai, A. Ido, Tatsunori Masatani, et al.. (2018). Transcriptional activities of two newly identified Haemaphysalis longicornis tick‐derived promoter regions in the Ixodes scapularis tick cell line (ISE6). Insect Molecular Biology. 27(5). 590–602. 9 indexed citations
2.
Kobayashi, Satoshi, Kazuomi Ueshima, Michihisa Moriguchi, et al.. (2017). JET-HCC: A phase 3 randomized, double-blind, placebo-controlled study of tivantinib as a second-line therapy in patients with c-Met high hepatocellular carcinoma. Annals of Oncology. 28. v210–v210. 19 indexed citations
3.
Komaki, Yuga, Fukiko Komaki, Akihiro Yamada, et al.. (2017). Meta‐Analysis of the Risk of Immune‐Related Adverse Events With Anticytotoxic T‐Lymphocyte‐Associated Antigen 4 and Antiprogrammed Death 1 Therapies. Clinical Pharmacology & Therapeutics. 103(2). 318–331. 21 indexed citations
4.
Komaki, Yuga, Akihiro Yamada, Fukiko Komaki, et al.. (2017). Systematic review with meta‐analysis: the efficacy and safety of CT‐P13, a biosimilar of anti‐tumour necrosis factor‐α agent (infliximab), in inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics. 45(8). 1043–1057. 83 indexed citations
5.
Kanmura, Shuji, et al.. (2017). P107 Lactobacillus plantarum 06CC2 induces intestinal IL-10–producing dendritic cells to ameliorate acute experimental colitis in mice. Journal of Crohn s and Colitis. 11(suppl_1). S130–S130. 1 indexed citations
6.
Taguchi, Hiroki, et al.. (2016). Evaluation of a Proton Pump Inhibitor for Sleep Bruxism. Journal of Dental Research. 95(13). 1479–1486. 20 indexed citations
7.
Waseda, Yuma, et al.. (2012). A Case of Hereditary Persistence of  -Fetoprotein: Diagnostic Usefulness of the Subfraction Profile. Japanese Journal of Clinical Oncology. 42(8). 767–769. 5 indexed citations
8.
Uto, Hirofumi, Katsuhiro Hayashi, Kazunori Kusumoto, et al.. (2005). Spontaneous elimination of hepatitis C virus RNA in individuals with persistent infection in a hyperendemic area of Japan. Hepatology Research. 34(1). 28–34. 16 indexed citations
10.
Hayashi, Katsuhiro, Satoru Hasuike, Kazunori Kusumoto, et al.. (2005). Usefulness of a new immuno‐radiometric assay to detect hepatitis C core antigen in a community‐based population. Journal of Viral Hepatitis. 12(1). 106–110. 21 indexed citations
11.
Uto, Hirofumi, A. Ido, Kenji Kusumoto, et al.. (2005). Development of a rapid semi-quantitative immunochromatographic assay for serum hepatocyte growth factor and its usefulness in acute liver failure. Hepatology Research. 33(4). 272–276. 3 indexed citations
13.
Kuroki, Manabu, Hirofumi Uto, A. Ido, et al.. (2000). [A case of gallbladder cancer producing granulocyte-colony stimulating factor and possible parathyroid hormone related protein].. PubMed. 97(4). 478–83. 9 indexed citations
14.
Ishikawa, Hiroki, Kensuke Nakata, A. Ido, et al.. (1999). Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma. Gene Therapy. 6(4). 465–470. 34 indexed citations
15.
Nakata, Kensuke, A. Ido, Hiroki Ishikawa, et al.. (1998). Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice.. International Journal of Molecular Medicine. 1(4). 671–5. 14 indexed citations
16.
Nakata, Keisuke, Takuya Tsutsumi, A. Ido, et al.. (1996). Enhanced expression of hepatitis B surface antigen by sodium butyrate in PLC/PRF/5 human hepatoma cells. International Journal of Oncology. 9(2). 285–9. 1 indexed citations
18.
Nakata, Keisuke, et al.. (1992). A possible mechanism of inverse developmental regulation of alpha-fetoprotein and albumin genes. Studies with epidermal growth factor and phorbol ester.. Journal of Biological Chemistry. 267(2). 1331–1334. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026